From: Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
DLBCL cell lines
RBF 197 (µM)
RBF208 (µM)
OCILy3
0.4
0.9
SUDHL4
3.2
4.5
Farage
2.4
2.9
DS
2.8
4.3
RC
1.9
5.2
SUDHL2
> 30